Patients Deserve an Explanation
This article is part of an ongoing series addressing persistent myths about Lyme disease.
One of the most common—and most important—questions I hear from patients is: “If my Lyme test is negative, why are you still treating me?”
It’s a fair question. And if you’re asking it, you deserve a clear and compassionate answer. The truth is, when it comes to Lyme disease, test results don’t always tell the full story.
Let’s break down why.
Lyme Disease Testing Isn’t Always Reliable
The standard test used to diagnose Lyme disease is called the two-tier system. It includes an ELISA screening test followed by a Western blot if the first result is positive. But this system is far from perfect—especially when the infection is in its early or late stages.
Here’s what you should know: Early in the infection, your body may not have produced enough antibodies yet to trigger a positive result. Some patients never produce detectable antibodies at all. Co-infections like Babesia or Bartonella are not picked up by this test. Many rashes don’t appear in the textbook “bulls-eye” pattern—or don’t appear at all.
So yes—you can absolutely have Lyme disease, even if your test is negative. And unfortunately, this is more common than many realize.
In Medicine, We Don’t Wait for Disease to Get Worse
In most areas of healthcare, we don’t wait for a serious event before we start treatment. We don’t wait for a stroke to treat high blood pressure. We don’t wait for vision loss to manage diabetes. We don’t wait for full organ failure to address chronic kidney disease.
We act early—because we know that early treatment improves outcomes. So why does Lyme disease often get treated differently?
When it comes to Lyme, many patients are told to “wait and see”—even when the symptoms are clear and distressing.
Waiting Is Not a Neutral Decision
Here’s what I tell my patients: Waiting is not harmless. It’s a medical decision with consequences.
Delaying treatment can allow symptoms to worsen. It can allow the infection to persist or spread. In some cases, patients who were told to wait eventually end up with a label: Post-Treatment Lyme Disease Syndrome (PTLDS)—a condition where symptoms linger long after the initial infection was treated, or in some cases, never properly treated at all.
What if we had treated earlier? Could we have prevented months—or even years—of suffering?
In many cases, the answer is yes.
Clinical Judgment Is Not Guesswork
When I decide to treat someone for Lyme disease despite a negative test, it’s not a random decision. It’s based on the full pattern of symptoms, medical history, response to prior treatments, known or likely tick exposure, and experience with thousands of Lyme patients.
This is called clinical judgment. It’s a core part of good medical practice. I don’t ignore science—I apply it in context. Because Lyme doesn’t always follow the rules, and neither should we when those rules are failing genuine people.
You Know When Something Feels Wrong
I’ve met patients who’ve been told their symptoms are “just stress” or “hormonal” or “all in their head.” But they know their bodies. They’ve tracked their fatigue, their joint pain, their cognitive changes. They’ve seen something shift—and they’re right to speak up about it.
Many of those patients improve once treatment begins, even if their test results never confirmed the diagnosis. That’s not luck. That’s Lyme disease showing up in genuine life—even when it doesn’t show up in the lab.
It’s Time to Rethink How We Treat Lyme
We’re in a new era of medicine. Patients are more informed, more proactive, and more in tune with their own health than ever before. But too often, our Lyme diagnostic standards are stuck in the past—waiting for certainty while people lose months or years of their lives to untreated illness.
We need to bring clinical judgment back into focus. We need to listen more, wait less, and treat Lyme disease with the urgency it deserves.
Frequently Asked Questions
Can you have Lyme disease with a negative test?
Yes. Early in infection, antibodies may not have developed yet. Some patients never produce detectable antibodies. Testing limitations mean negative results don’t rule out Lyme disease.
Why would a doctor treat Lyme without a positive test?
Clinical judgment based on symptoms, exposure history, and response to treatment is medically appropriate when testing is unreliable. Waiting for a positive test can allow the infection to progress.
Is treating without a positive test considered good medical practice?
Yes. The CDC states that Lyme disease is a clinical diagnosis supported by laboratory testing—not defined by it. When clinical suspicion is high, treatment is warranted.
What if I improve with treatment but never tested positive?
Improvement with appropriate antibiotic therapy supports the diagnosis of Lyme disease, even when testing was negative. Response to treatment is valuable diagnostic information.
Should I wait for a positive test before starting treatment?
Waiting is not neutral—it’s a medical decision with consequences. Early treatment improves outcomes. Delaying care can allow symptoms to worsen and the infection to spread.
Clinical Takeaway
If you’ve been told your test is negative, but you’re still struggling with symptoms—please know this: You’re not imagining it. You’re not overreacting. And you’re not alone. In my practice, I treat the whole patient—not just the lab result. Because when it comes to Lyme disease with a negative test, early treatment based on clinical judgment can change everything. You deserve to be heard.
Related Reading
- Lyme Disease Testing and Diagnosis
- Understanding Lyme Disease Test Accuracy
- How to Test for Lyme Disease: Beyond CDC Guidelines
- Relying on a Negative Lyme Disease Test Can Prove Deadly
- Don’t Wait for a Positive Lyme Disease Test
- Ethical Lyme Disease Care: When Clinical Judgment Matters
- Lyme Disease Misconceptions
- Preventing Long-Term Lyme Disease
- Post-Treatment Lyme Disease Syndrome (PTLDS)
References
- Centers for Disease Control and Prevention. Lyme Disease Diagnosis and Testing. Accessed 2025.